CPSI Announces Third Quarter 2016 Results

November 3, 2016 4:06 PM

Company Announces Quarterly Cash Dividend of $0.24 Per Share


Highlights for Third Quarter 2016:

CPSI (NASDAQ: CPSI), a leading provider of healthcare information solutions, today announced results for the third quarter and nine months ended September 30, 2016.

The Company also announced that its Board of Directors has declared a quarterly cash dividend of twenty-four cents ($0.24) per share, payable on December 2, 2016, to stockholders of record as of the close of business on November 17, 2016. This quarterly cash dividend is consistent with the variable dividend policy approved by the Company’s Board of Directors and previously announced on August 4, 2016.

Total revenues for the third quarter ended September 30, 2016, were $64.7 million, compared with total revenues of $44.6 million for the prior-year third quarter. Net income for the quarter ended September 30, 2016, was $1.6 million, or $0.12 per diluted share, compared with net income of $3.5 million, or $0.31 per diluted share, for the quarter ended September 30, 2015. Cash provided by operations for the third quarter of 2016 was $5.9 million, compared with $8.9 million for the prior-year third quarter.

Total revenues for the nine months ended September 30, 2016, were $202.7 million, compared with total revenues of $137.9 million for the prior-year period. Net income for the nine months ended September 30, 2016, was $1.9 million, or $0.15 per diluted share, compared with $15.0 million, or $1.32 per diluted share, for the nine months ended September 30, 2015. Cash used by operations for the first nine months of 2016 was $2.6 million, compared with cash provided by operations of $26.3 million for the prior-year period.

“While there are changing market dynamics creating a degree of uncertainty throughout our industry, we believe there is no better time to be investing in and focusing on our vision and the integral role we will play in the delivery of healthcare to rural communities in the coming years,” said Boyd Douglas, president and chief executive officer of CPSI. “In collaboration with those organizations and providers who are caring for those rural communities every day, we share a common goal of keeping these organizations strong and their communities healthy. We continue to be extremely pleased with the positive impact the Healthland acquisition is having on our current business, our future position in the market and within our customer base. Our Healthland customer retention rates continue to hold strong following the acquisition, supporting an expected increase in our services revenue and paving the way for increased demand of future add-on sales associated with MU3, as well as new solutions and services that will support population health.”

Commenting on the Company's financial performance for the quarter, Matt Chambless, chief financial officer of CPSI, stated, “Despite the negative effect on the third quarter’s revenues caused by a heavy mix of cloud-based Thrive EHR installations, this quarter marked a return to positive operating cash flows for the Company. The working capital investments we made during the second quarter of 2016 have proven to be more than adequate, and our post-acquisition integration and synergy plans continue to be managed and executed effectively.”

“Our pipeline for system sales continues to be strong and remains in line with pre-Meaningful Use levels; however, with the current replacement market, we are managing a slowdown in the conversion of our pipeline to bookings. Coupled with the end of government stimulus funding as a strong driver for add-on sales, this has created a challenging environment for achieving our desired levels of system sales and bookings growth. We continue to be encouraged by the traction that TruBridge and Rycan are gaining into our expanded customer base, including our post-acute care clients. We view these as key factors in supporting continued growth in our recurring revenues, improved profitability, and enhanced returns for our shareholders,” added Chambless.

Douglas concluded, “Our family of companies is focused on all aspects of healthcare delivery from ambulatory to acute care to post-acute care, encompassing not only the clinical aspects, but the financial operations as well. With this framework, we are in a very unique position to help our clients successfully navigate the challenges ahead.”

CPSI will hold a live webcast to discuss third quarter 2016 results today, Thursday, November 3, 2016, at 4:30 p.m. Eastern time. A 30-day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company's website, www.cpsi.com.

About CPSI

CPSI is a leading provider of healthcare IT solutions and services for rural and community hospitals and post-acute care facilities. Founded in 1979, CPSI is the parent of five companies – Evident, LLC, TruBridge, LLC, Healthland Inc., American HealthTech, Inc., and Rycan Technologies, Inc. Our combined company is focused on helping improve the health of the communities we serve, connecting communities for a better patient care experience, and improving the financial operations of our customers. Evident provides comprehensive EHR solutions and services for rural and community hospitals. TruBridge focuses exclusively on providing business management, consulting and managed IT services to rural and community healthcare organizations, regardless of their IT vendor. Healthland provides integrated technology solutions and services to small rural and critical access hospitals. American HealthTech is one of the nation’s largest providers of financial and clinical technology solutions and services for post-acute care facilities. Rycan provides revenue cycle management workflow and automation software to hospitals, healthcare systems, and skilled nursing organizations. For more information, visit www.cpsi.com, www.evident.com, www.trubridge.com, www.healthland.com, www.healthtech.net, or www.rycan.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as "expects," "anticipates," "estimates," "believes," "predicts," "intends," "plans," "potential," "may," "continue," "should," "will" and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, shareholder returns and future financial results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: overall business and economic conditions affecting the healthcare industry, including the potential effects of the federal healthcare reform legislation enacted in 2010, and implementing regulations, on the businesses of our hospital customers; government regulation of our products and services and the healthcare and health insurance industries, including changes in healthcare policy affecting Medicare and Medicaid reimbursement rates and qualifying technological standards; changes in customer purchasing priorities, capital expenditures and demand for information technology systems; saturation of our target market and hospital consolidations; general economic conditions, including changes in the financial and credit markets that may affect the availability and cost of credit to us or our customers; our substantial indebtedness, and our ability to incur additional indebtedness in the future; our inability to generate sufficient cash in order to meet our debt service obligations; restrictions on our current and future operations because of the terms of our senior secured credit facilities; market risks related to interest rate changes; our ability to successfully integrate the businesses of Healthland, American HealthTech and Rycan with our business and the inherent risks associated with any potential future acquisitions; competition with companies that have greater financial, technical and marketing resources than we have; failure to develop new or enhance current technology and products in response to market demands; failure of our products to function properly resulting in claims for losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases or enhancements free of undetected errors or problems; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; our ability to attract and retain qualified customer service and support personnel; failure to properly manage growth in new markets we may enter; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; changes in accounting principles generally accepted in the United States; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K. Relative to our dividend policy, the payment of cash dividends is subject to the discretion of our Board of Directors and will be determined in light of then-current conditions, including our earnings, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our Board of Directors. In the future, our Board of Directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.


Unaudited Condensed Consolidated Statements of Income

(in thousands, except per share data)

Three Months Ended

September 30,

Nine Months Ended

September 30,

2016 2015 2016 2015
Sales revenues:
System sales and support $ 47,329 $ 28,094 $ 150,270 $ 90,021

Business management, consulting and managed IT services

17,334 16,523 52,451 47,922

Total sales revenues





Costs of sales:
System sales and support 21,739 12,825 68,968 40,126
Business management, consulting and managed IT services 9,973 9,065 29,414 25,929
Total costs of sales 31,712 21,890 98,382 66,055
Gross profit 32,951 22,727 104,339 71,888
Operating expenses:
Product development 8,397 3,554 23,766 10,706
Sales and marketing 6,894 4,564 20,341 13,895
General and administrative 10,815 10,348 42,370 26,806

Amortization of acquisition-related intangibles

2,601 7,580
Total operating expenses 28,707 18,466 94,057 51,407
Operating income 4,244 4,261 10,282 20,481
Other income (expense):
Other income 53 137 121 335
Interest expense (1,717 ) (4,828 )
Total other income (expense) (1,664 ) 137 (4,707 ) 335
Income before taxes 2,580 4,398 5,575 20,816
Provision for income taxes 981 859 3,643 5,865
Net income $ 1,599 $ 3,539 $ 1,932 $ 14,951

Net income per common share - basic and diluted

$ 0.12 $ 0.31 $ 0.15 $ 1.32

Weighted average shares outstanding used in per common share computations – basic and diluted

13,327 11,091 13,224 11,074


Condensed Consolidated Balance Sheets

(in thousands, except per share data)

Sept. 30,2016

Dec. 31,


Current assets:
Cash and cash equivalents $ 3,656 $ 24,951
Investments - 10,824

Accounts receivable, net of allowance for doubtful accounts of $1,797 and $1,216, respectively

29,943 22,594
Financing receivables, current portion, net 7,628 10,576
Inventories 1,681 1,495
Deferred tax assets - 2,335
Prepaid income taxes 1,264 427
Prepaid expenses and other 3,776 1,356
Total current assets 47,948 74,557
Property and equipment, net 14,164 14,351
Financing receivables, net of current portion 4,607 1,569
Intangible assets, net 109,720 -
Goodwill 166,109 -
Deferred tax assets - 2,311
Total assets $ 342,548 $ 92,788
Current liabilities:
Accounts payable $ 7,334 $ 4,591
Current portion of long-term debt 5,075 -
Deferred revenue 8,655 3,821
Accrued vacation 4,873 3,412
Other accrued liabilities 8,068 5,598
Total current liabilities 34,005 17,422
Long-term debt, less current portion 150,587 -
Deferred tax liabilities 1,707 -
Total liabilities 186,299 17,422
Stockholders' equity:
Common stock, par value $0.001 per share, 30,000 shares authorized, 13,533 and 11,303 shares issued and outstanding 13 11
Additional paid-in capital 144,943 44,187
Accumulated other comprehensive loss - (38 )
Retained earnings 11,293 31,206
Total stockholders' equity 156,249 75,366
Total liabilities and stockholders' equity $ 342,548 $ 92,788


Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

Nine Months Ended

September 30,

2016 2015
Operating activities:
Net income $ 1,932 $ 14,951
Adjustments to net income:
Provision for bad debt 722 741
Deferred taxes 3,735 (1,250 )
Stock-based compensation 4,023 3,998
Deficient (excess) tax benefit from stock-based compensation (50 ) 211
Depreciation 2,422 2,499
Intangible amortization 7,580 -
Amortization of deferred finance costs 501 -
Changes in operating assets and liabilities:
Accounts receivable (1,489 ) 365
Financing receivables 1,301 4,000
Inventories 31 (90 )
Prepaid expenses and other 808 (688 )
Accounts payable (5,095 ) 824
Deferred revenue (11,365 ) (2,012 )
Other liabilities (6,841 ) 3,054
Income taxes payable/prepaid income taxes (788 ) (278 )
Net cash (used in) provided by operating activities (2,573 ) 26,325
Investing activities:
Purchases of property and equipment (39 ) (447 )
Purchases of investments - (117 )
Purchase of business, net of cash received (162,611 ) -
Sale of investments 10,861 -
Net cash used in investing activities (151,789 ) (564 )
Financing activities:
Dividends paid (21,845 ) (21,709 )
Proceeds from long-term debt 156,572 -
Payments of long-term debt (2,344 ) -
Payments of contingent consideration (500 ) -
Proceeds from stock option exercise 1,134 -
Excess (deficit) tax benefit from stock-based compensation 50 (211 )
Net cash provided by (used in) financing activities 133,067 (21,920 )
Net (decrease) increase in cash and cash equivalents (21,295 ) 3,841
Cash and cash equivalents, beginning of period 24,951 23,792
Cash and cash equivalents, end of period $ 3,656 $ 27,633


Unaudited Other Supplemental Information

Consolidated Bookings

(in thousands)

Three Months Ended

September 30,

Nine Months Ended

September 30,

2016 2015 2016 2015
System sales and support(1) $ 16,955 $ 13,132 $ 55,541 $ 41,038

Business management, consulting and managed IT services(2)

3,929 5,582 12,442 15,735
Total $ 20,884 $ 18,714 $ 67,983 $ 56,773
(1) Generally calculated as the total contract price (for system sales) and annualized contract value (support).
(2) Generally calculated as the total contract price (for non-recurring, project-related amounts) and annualized contract value (for recurring amounts).


Reconciliation of Non-GAAP Financial Measures

(in thousands, except per share data)

Adjusted EBITDA Three Months Ended

September 30,

Nine Months Ended

September 30,

2016 2015 2016 2015
Net income, as reported $ 1,599 $ 3,539 $ 1,932 $ 14,951
Deferred revenue and other acquisition-related adjustments 516 - 2,226 -
Depreciation expense 682 673 2,422 2,499
Amortization of acquisition-related intangible assets 2,601 - 7,580 -
Stock-based compensation 1,146 1,383 4,023 3,998
Transaction-related costs 69 - 8,087 -
Interest expense and other, net 1,664 (137 ) 4,707 (335 )
Provision for income taxes, net of cash benefits from NOL utilization 3,519 859 8,689 5,865
Adjusted EBITDA $ 11,796 $ 6,317 $ 39,666 $ 26,978
Non-GAAP Net Income and Non-GAAP Earnings Per Share ("EPS") Three Months Ended

September 30,

Nine Months Ended

September 30,

2016 2015 2016 2015
Net income, as reported $ 1,599 $ 3,539 $ 1,932 $ 14,951
Pre-tax adjustments for Non-GAAP EPS:
Deferred revenue and other adjustments 516 - 2,226 -
Amortization of acquisition-related intangible assets 2,601 - 7,580 -
Stock-based compensation 1,146 1,383 4,023 3,998
Transaction-related costs 69 - 8,087 -
Non-cash interest expense 172 - 501 -
After-tax adjustments for Non-GAAP EPS:
Tax-effect of pre-tax adjustments, at 35% (1,576 ) (484 ) (7,846 ) (1,399 )
Tax-effect of non-deductible transaction-related costs (60 ) - 1,410 -
Non-GAAP net income $ 4,467 $ 4,438 $ 17,913 $ 17,550
Weighted average shares outstanding, diluted 13,327 11,091 13,224 11,074
Non-GAAP EPS $ 0.34 $ 0.40 $ 1.35 $ 1.58

Explanation of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States of America, or “GAAP.” However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures that are prepared in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management uses these non-GAAP financial measures in order to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. In addition, management understands that some investors and financial analysts find these non-GAAP financial measures helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

As such, to supplement the GAAP information provided, we present in this press release the following non-GAAP financial measures: Adjusted EBITDA, Non-GAAP net income, and Non-GAAP earnings per share (“EPS"). -END-

We calculate each of these non-GAAP financial measures as follows:

Certain of the items excluded or adjusted to arrive at these non-GAAP financial measures are described below:

Management considers these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance. In addition, management may use Adjusted EBITDA, Non-GAAP net income and/or Non-GAAP EPS to measure the achievement of performance objectives under the Company’s stock and cash incentive programs. Note, however, that these non-GAAP financial measures are performance measures only, and they do not provide any measure of cash flow or liquidity. Non-GAAP financial measures are not alternatives for measures of financial performance prepared in accordance with GAAP and may be different from similarly titled non-GAAP measures presented by other companies, limiting their usefulness as comparative measures. Non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Additionally, there is no certainty that we will not incur expenses in the future that are similar to those excluded in the calculation of the non-GAAP financial measures presented in this press release. Investors and potential investors are encouraged to review the “Reconciliation of Non-GAAP Financial Measures” above.


Boyd Douglas, 251-639-8100

President and Chief Executive Officer

Source: CPSI


Press Releases

Next Articles